Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort

被引：10

作者：

Casco, Nicolas ^{[1
]}

Levi Jorge, Alberto ^{[1
]}

Juan Palmero, Domingo ^{[1
]}

Alffenaar, Jan-Willem ^{[2
,3
,4
]}

Fox, Greg J. ^{[5
]}

Ezz, Wafaa ^{[5
]}

Cho, Jin-Gun ^{[2
,6
,7
]}

Denholm, Justin ^{[8
,9
]}

Skrahina, Alena ^{[10
]}

Solodovnikova, Varvara ^{[10
]}

Arbex, Marcos Abdo ^{[11
]}

Alves, Tatiana ^{[12
]}

Rabahi, Marcelo Fouad ^{[13
]}

Pereira, Giovana Rodrigues ^{[14
]}

Sales, Roberta ^{[15
]}

Silva, Denise Rossato ^{[16
]}

Saffie, Muntasir M. ^{[17
]}

Escobar Salinas, Nadia ^{[18
]}

Caamano Miranda, Ruth ^{[19
]}

Cisterna, Catalina ^{[19
]}

Concha, Clorinda ^{[19
]}

Fernandez, Israel ^{[19
]}

Villalon, Claudia ^{[19
]}

Guajardo Vera, Carolina ^{[19
]}

Gallegos Tapia, Patricia ^{[19
]}

Cancino, Viviana ^{[20
]}

Carbonell, Monica ^{[20
]}

Cruz, Arturo ^{[20
]}

Munoz, Eduardo ^{[20
]}

Munoz, Camila ^{[20
]}

Navarro, Indira ^{[20
]}

Pizarro, Rolando ^{[20
]}

Cristina Sanchez, Gloria Pereira ^{[20
]}

Vergara Riquelme, Maria Soledad ^{[20
]}

Vilca, Evelyn ^{[20
]}

Soto, Aline ^{[20
]}

Flores, Ximena ^{[21
]}

Garavagno, Ana ^{[21
]}

Hartwig Bahamondes, Martina ^{[21
]}

Moyano Merino, Luis ^{[21
]}

Maria Pradenas, Ana ^{[21
]}

Espinoza Revillot, Macarena ^{[21
]}

Rodriguez, Patricia ^{[21
]}

Serrano Salinas, Angeles ^{[22
]}

Taiba, Carolina ^{[22
]}

Farias Valdes, Joaquin ^{[23
]}

Navarro Subiabre, Jorge ^{[24
]}

Ortega, Carlos ^{[25
]}

Palma, Sofia ^{[26
]}

Perez Castillo, Patricia ^{[27
]}

机构：

[1] Inst Tisioneumonol Prof Dr R Vaccarezza, Buenos Aires, Argentina

[2] Univ Sydney, Sydney Inst Infect Dis, Sydney, Australia

[3] Univ Sydney, Sch Pharm, Fac Med & Hlth, Sydney, Australia

[4] Westmead Hosp, Sydney, Australia

[5] Univ Sydney, Sydney Sch Med, Fac Med & Hlth, Sydney, Australia

[6] Parramatta Chest Clin, Parramatta, Australia

[7] Westmead Hosp, Westmead, Australia

[8] Melbourne Hlth, Victorian TB Program, Melbourne, Vic, Australia

[9] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Infect Dis, Parkville, Australia

[10] Republican Res & Pract Ctr Pulmonol & TB, Minsk, BELARUS

[11] Univ Araraquara, Fac Med, Area Temat Pneumol, Araraquara, Brazil

[12] Univ Fed Bahia, Salvador, Brazil

[13] Univ Fed Goias, Fac Med, Goiania, Go, Brazil

[14] Secretaria Municipal Saude, Lab Municipal Alvorada, Alvorada, Brazil

[15] Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Inst Coracao,Div Pneumol, Sao Paulo, Brazil

[16] Univ Fed Rio Grande do Sul UFRGS, Fac Med, Porto Alegre, Brazil

[17] McMaster Univ, Div Respirol, Hamilton, ON, Canada

[18] Minist Salud Chile, Programa Nacl TB, Santiago, Chile

[19] Serv Salud Metropolitano Cent, Santiago, Chile

[20] Serv Salud Metropolitano Sur, Santiago, Chile

[21] Serv Salud Metropolitano Oriente, Providencia, Chile

[22] Serv Salud Metropolitano Occidente, Santiago, Chile

[23] Serv Salud Iquique, Iquique, Chile

[24] Serv Salud Valparaiso San Antonio, Valparaiso, Chile

[25] Serv Salud Concepcion, Concepcion, Chile

[26] Hosp DIPRECA, Las Condes, Chile

[27] Serv Salud Antofagasta, Antofagasta, Chile

[28] Serv Salud Magallanes, Punta Arenas, Chile

[29] Serv Salud Talcahuano, Talcahuano, Chile

[30] Serv Salud Arica, Arica, Chile

[31] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai, Peoples R China

[32] Minist Salud & Protecc Social, Bogota, Colombia

[33] Secretaria Salud Dept, Cauca, Colombia

[34] Univ Cauca, Dept Med Interna, Grp Invest TB, Popayan, Colombia

[35] Catholic Univ Cuenca, Cuenca, Ecuador

[36] WHO Reg Off Eastern Mediterranean Reg, Cairo, Egypt

[37] CHU Amiens Picardie, Resp Dept, Amiens, France

[38] Picardie Jules Verne Univ, UR 4294, AGIR, Amiens, France

[39] Nantes Univ, CHU Nantes, Inst Thorax, Serv Pneumol, Nantes, France

[40] Grp Hosp Sud Ile de France GHSIF, Serv Pneumol, Melun, France

[41] Intermunicipal Hosp Ctr Creteil, Dept Internal Med, Creteil, France

[42] North Cardiol Ctr, Pneumol Dept, St Denis, France

[43] Hop Instruct Armees Percy, Dept Pneumol, Clamart, France

[44] Hop Univ Henri Mondor, AP HP, Unite Pneumol, Creteil, France

[45] Univ Paris Est Creteil, Fac Sante, INSERM, IMRB, Creteil, France

[46] Aristotle Univ Thessaloniki, Pulm Dept, Thessaloniki, Greece

[47] Univ Gamal Abdel Nasser Conakry, CHU Conakry, Fac Sci & Tech Sante, Serv Pneumophtisiol, Conakry, Guinea

[48] Hop Natl Ignace Deen, Conakry, Guinea

[49] Damien Fdn, Conakry, Guinea

[50] Secretaria Salud Honduras, Natl TB Programme, Tegucigalpa, Honduras

来源：

EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷 / 05期

关键词：

EXTREMELY PRETERM; LUNG-FUNCTION; SCHOOL-AGE; BIRTH; EXERCISE; CHILDREN; INFANTS; IMPAIRMENT; SURVIVORS; MEMBRANE;

D O I：

10.1183/13993003.00925-2023

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Background Longitudinal cohort data of patients with tuberculosis (TB) and coronavirus disease 2019 (COVID-19) are lacking. In our global study, we describe long-term outcomes of patients affected by TB and COVID-19. Methods We collected data from 174 centres in 31 countries on all patients affected by COVID-19 and TB between 1 March 2020 and 30 September 2022. Patients were followed-up until cure, death or end of cohort time. All patients had TB and COVID-19; for analysis purposes, deaths were attributed to TB, COVID-19 or both. Survival analysis was performed using Cox proportional risk-regression models, and the log-rank test was used to compare survival and mortality attributed to TB, COVID-19 or both. Results Overall, 788 patients with COVID-19 and TB (active or sequelae) were recruited from 31 countries, and 10.8% (n=85) died during the observation period. Survival was significantly lower among patients whose death was attributed to TB and COVID-19 versus those dying because of either TB or COVID-19 alone (p<0.001). Significant adjusted risk factors for TB mortality were higher age (hazard ratio (HR) 1.05, 95% CI 1.03-1.07), HIV infection (HR 2.29, 95% CI 1.02-5.16) and invasive ventilation (HR 4.28, 95% CI 2.34-7.83). For COVID-19 mortality, the adjusted risks were higher age (HR 1.03, 95% CI 1.02-1.04), male sex (HR 2.21, 95% CI 1.24-3.91), oxygen requirement (HR 7.93, 95% CI 3.44- 18.26) and invasive ventilation (HR 2.19, 95% CI 1.36-3.53). Conclusions In our global cohort, death was the outcome in >10% of patients with TB and COVID-19. A range of demographic and clinical predictors are associated with adverse outcomes.

引用

页数：12

共 50 条

[1] Tuberculosis and COVID-19 co-infection: description of the global cohort
Casco, Nicolas
Jorge, Alberto Levi
Palmero, Domingo Juan
Alffenaar, Jan-Willem
Denholm, Justin
Fox, Greg J.
Ezz, Wafaa
Cho, Jin-Gun
Skrahina, Alena
Solodovnikova, Varvara
Bachez, Pierre
Piubello, Alberto
Arbex, Marcos Abdo
Alves, Tatiana
Rabahi, Marcelo Fouad
Pereira, Giovana Rodrigues
Sales, Roberta
Silva, Denise Rossato
Saffie, Muntasir M.
Miranda, Ruth Caamano
Cancino, Viviana
Carbonell, Monica
Cisterna, Catalina
Concha, Clorinda
Cruz, Arturo
Salinas, Nadia Escobar
Revillot, Macarena Espinoza
Valdes, Joaquin Farias
Fernandez, Israel
Flores, Ximena
Tapia, Patricia Gallegos
Garavagno, Ana
Vera, Carolina Guajardo
Bahamondes, Martina Hartwig
Merino, Luis Moyano
Munoz, Eduardo
Munoz, Camila
Navarro, Indira
Subiabre, Jorge Navarro
Ortega, Carlos
Palma, Sofia
Pradenas, Ana Maria
Pereira, Gloria
Castillo, Patricia Perez
Pinto, Monica
Pizarro, Rolando
Bidegain, Francisco Rivas
Rodriguez, Patricia
Sanchez, Cristina
Salinas, Angeles Serrano
EUROPEAN RESPIRATORY JOURNAL, 2022, 59 (03)
[2] Long-term outcome of co-infection of COVID-19 and tuberculosis: the "cursed duet"
Diel, Roland
Schluger, Neil W.
EUROPEAN RESPIRATORY JOURNAL, 2023, 62 (05)
[3] Co-infection of COVID-19 and Tuberculosis
Kilic, Lutfiye
Altin, Sedat
Ortakoylu, Mediha Gonenc
Kanmaz, Zehra Dilek
Tutar, Tayjen
Ozkan, Gulcihan Zehra
TURKISH THORACIC JOURNAL, 2022, 23 (01): : 58 - 62
[4] On tuberculosis and COVID-19 co-infection
Tadolini, Marina
Garcia-Garcia, Jose-Maria
Blanc, Francois-Xavier
Borisov, Sergey
Goletti, Delia
Motta, Ilaria
Codecasa, Luigi Ruffo
Tiberi, Simon
Sotgiu, Giovanni
Migliori, Giovanni Battista
EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (02)
[5] Co-infection of pulmonary tuberculosis and Covid-19
Laushkina, Zhanna
EUROPEAN RESPIRATORY JOURNAL, 2021, 58
[6] Evaluation of tuberculosis infection in COVID-19 patients: a case of tuberculosis and COVID-19 co-infection
Niazkar, Hamid Reza
Zibaee, Behdad
Razavi, Seyed Behzad
Ghanaeian, Kasra
Talebzadeh, Vahid
Vosugh, Negin Haji
EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2022, 34 (01):
[7] Evaluation of tuberculosis infection in COVID-19 patients: a case of tuberculosis and COVID-19 co-infection
Hamid Reza Niazkar
Behdad Zibaee
Seyed Behzad Razavi
Kasra Ghanaeian
Vahid Talebzadeh
Negin Haji Vosugh
The Egyptian Journal of Internal Medicine, 2022, 34
[8] Co-infection in COVID-19, a cohort study
Song, Wuhui
Jia, Xiaofang
Zhang, Xiaonan
Ling, Yun
Yi, Zhigang
JOURNAL OF INFECTION, 2021, 82 (03) : 440 - 442
[9] Long-term sequelae of TB and COVID-19 co-infection: Prospective cohort evaluation after 1 year
Silva, D. R.
dos Santos, A. P. C.
Centis, R.
D'Ambrosioe, L.
Migliori, G. B.
PULMONOLOGY, 2023, 29 (06): : 535 - 539
[10] COVID-19 and tuberculosis co-infection: a neglected paradigm
Bandyopadhyay, Arkapal
Palepu, Sarika
Bandyopadhyay, Krishna
Handu, Shailendra
MONALDI ARCHIVES FOR CHEST DISEASE, 2020, 90 (03) : 518 - 522

← 1 2 3 4 5 →